Patents Assigned to Technion Research & Development
-
Patent number: 12369777Abstract: A modular robotic surgical system comprising: a base; a plurality of tool-receivers arranged as separate units, each tool-receiver unit operable to move an elongate surgical tool received therein; a plurality of interface coupling pairs, each coupling pair comprising a first coupler as part of the base and a second coupler as part of each of the tool-receiver units; wherein each of the tool-receiver units is independently and interchangeably attachable to the base via the coupling pair.Type: GrantFiled: November 26, 2020Date of Patent: July 29, 2025Assignees: Microbot Medical Ltd., Technion Research & Development Foundation LimitedInventors: Simon Sharon, Idan Boader, Evgeny Kofman, Eran Cohen, Eyal Morag, Harel Gadot, Moshe Shoham
-
Publication number: 20250235341Abstract: An orthosis apparatus for offloading weight from a foot of a patient, comprising: a leg brace, sized and shaped to attach to an area above the ankle and at least one foot support component, comprising a contact plate, wherein the at least one foot support component is connected to the leg brace; wherein the contact plate comprises a convex curve shaped region, sized and shaped to provide a rolling motion when contacting a surface; wherein the contact plate is positioned at the side of the foot, at a height which can be selected to be above, below or at the bottom of the foot surface; and wherein the orthosis apparatus is configured to offload weight by providing support extending downwards to the contact plate.Type: ApplicationFiled: June 27, 2024Publication date: July 24, 2025Applicant: Technion Research & Development Foundation LimitedInventors: Dana SOLAV, Etamar BAREKET, Hadas HUBER, Lee Jordan DOTAN, Eshraq SAFFURI
-
Patent number: 12364706Abstract: Modified aminoglycoside compounds represented by Formula I as defined and described in the specification are provided. The modified aminoglycosides feature a diamine-containing functional moiety at one or more of positions 3?, 4? and 6?. Uses of the modified aminoglycosides as antimicrobial (e.g., antibacterial) agents, and in treating medical conditions associated with microorganisms, are also provided.Type: GrantFiled: May 20, 2021Date of Patent: July 22, 2025Assignee: Technion Research & Development Foundation LimitedInventors: Timor Baasov, Boris Smolkin, Alina Khononov, Michal Shavit Kishkober, Valery Belakhov
-
Patent number: 12346297Abstract: There is provided a method of computing lineage, comprising: managing a dataset of records, each record associated with set(s) of vectors of real numbers that encode an approximation of lineage of the respective record, the set(s) of vectors computed by an encoding process, obtaining result record(s) in response to executing a query on the dataset, computing set(s) of vectors for the result record(s), searching the set(s) of vectors on the records of the dataset to identify a record associated with a subset of vectors that are statistically similar to the set(s) of vectors for the result record(s), and providing a subset of the records corresponding to the identified subset of records, the subset of the records having a likelihood of contributing to the existence of the result record(s) in response to execution of the query.Type: GrantFiled: August 16, 2022Date of Patent: July 1, 2025Assignee: Technion Research & Development Foundation LimitedInventors: Oded Shmueli, Michael Leybovich
-
Patent number: 12341510Abstract: An electronic memory block comprises phase change memory cells for memory storage and further phase change memory cells forming logic gates, to provide in-memory data processing.Type: GrantFiled: April 7, 2021Date of Patent: June 24, 2025Assignee: Technion Research & Development Foundation LimitedInventors: Shahar Kvatinsky, Barak Hoffer, Eilam Yalon, Nicolas Wainstein
-
Patent number: 12329784Abstract: The ubiquitin ligase, RNF5, regulates the gut microbiota composition and influences the immune checkpoint response to tumors. RNF5 deficient animals exhibit significant inhibition of tumor development as well as an altered gut microbiota composition. Methods of treating cancer by administering to a subject one or more selected bacterial species and/or one or more prebiotics that promote the growth of one or more selected bacterial species are disclosed. Also disclosed are methods of treating cancer by administering to a subject one or more selected bacterial species and/or one or more prebiotics that promote the growth of one or more selected bacterial species in combination with one or more anti-cancer agents.Type: GrantFiled: January 30, 2023Date of Patent: June 17, 2025Assignees: Sanford Burnham Prebys Medical Discovery Institute, Technion Research & Development Foundation Ltd.Inventors: Yan Li, Scott Peterson, Linda Bradley, Roberto Tinoco, Ze'ev Ronai, Shiri Ashkenazi
-
Publication number: 20250188755Abstract: A method for providing an architectural component, the method includes (i) receiving, by a computerized system, a request to design a manufacturing process of an architectural component; (ii) determining, by the computerized process, the manufacturing process by applying an interactive design process that takes into account interactions between (a) material composition parameters, (b) architectural design parameters, and (c) manufacturing parameters; wherein the manufacturing process is an additive three dimensional printing process; and (iii) responding to the designed manufacturing process.Type: ApplicationFiled: December 5, 2024Publication date: June 12, 2025Applicant: Technion Research & Development Foundation LimitedInventors: Aaron Sprecher, Arnon Bentur, Ofer Asaf, Pavel Larianovsky, Oded Amir, Eliad Michli
-
Publication number: 20250188150Abstract: An isolated peptide comprising an amino acid sequence of a lysyl oxidase (LOX) family member target site of an extracellular matrix protein, the peptide being no longer than 50 amino acids, for use in treating a disease associated with fibrosis in a subject in need thereof.Type: ApplicationFiled: February 11, 2025Publication date: June 12, 2025Applicant: Technion Research & Development Foundation LimitedInventors: Peleg HASSON, Haguy WOLFENSON, Shay MELAMED, Shelly EILOT, Elisabeth BOGER, Rohtem AVIRAM
-
Patent number: 12311360Abstract: Patterning a substrate can be provided. A substrate is covered by an immersion liquid and a microfluidic probe head is positioned in proximity with the surface of the substrate, so as to immerse a processing surface of the probe head in the immersion liquid. Liquid flows are generated between the processing surface of the probe head and the surface of the substrate, via the probe head. The liquid flows generated include an etching flow of an etching liquid (e.g., an acid or solvent) and a processing flow of a processing liquid (e.g., a solution or suspension).Type: GrantFiled: January 14, 2021Date of Patent: May 27, 2025Assignees: International Business Machines Corporation, Technion Research & Development Foundation LimitedInventors: Govind Kaigala, Federico Paratore, Moran Bercovici, Daniel Widerker, Robert Dean Lovchik
-
Patent number: 12293853Abstract: Provided herein are composite conductors, characterized by having copper deposits inside the bulk rather than on the outer surface of a non-metallic conductive porous matrix, such as CNT fabric, as well as a process for obtaining the same. The composite conductors provided herein are also characterized by a low specific weight and a high ampacity compared to metal conductors of similar size and shape.Type: GrantFiled: May 14, 2020Date of Patent: May 6, 2025Assignee: Technion Research & Development Foundation LimitedInventors: Yair Ein-Eli, Neta Yitzhack, Nina Sezin, David Starosvetsky
-
Publication number: 20250136719Abstract: The present invention relates to an heparanase-binding and heparanase-neutralizing monoclonal antibody (IgG-1 mAb A54), including its epitope (HBD-II) and mode of interaction with heparanase, pharmaceutical composition comprising same, and uses thereof e.g. for inhibiting or treating a disease or disorder associated with heparanase activity, including but not limited to cancer, inflammation, viral infection, diabetes and related complications. The present invention further provides combinatorial cancer therapies, comprising the heparanase-neutralizing mAb and an additional anti-cancer treatment such as chemotherapy or radiation.Type: ApplicationFiled: September 25, 2024Publication date: May 1, 2025Applicants: Technion Research & Development Foundation Limited, Hadasit Medical Research Services and Development Ltd.Inventors: Israel Vlodavsky, Uri Barash
-
Publication number: 20250122854Abstract: A direct gaseous reformate injector that includes an inlet for receiving a gaseous reformate; a plunger; and an outward-opening valve that comprises a valve body and a needle that is movable, by the plunger, in relation to the valve body, between a (a) closed position in which the gaseous reformate is not outputted from the direct gaseous reformate injector, and (b) an open position in which the gaseous reformate is outputted from the direct gaseous reformate injector.Type: ApplicationFiled: October 15, 2024Publication date: April 17, 2025Applicant: Technion Research & Development Foundation LimitedInventors: Leonid Tartakovsky, Asher Netzer Lichinitzer
-
Publication number: 20250114351Abstract: A method of treating a disease or disorder for which an increase in immune cells in the brain is therapeutic in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent which specifically binds and increases activity of a receptor selected from the group consisting of a 5HT2C receptor, a 5HT2A receptor and a 5HT2B receptor in the postcentral gyrus and/or the choroid plexus (CP) of the brain of the subject. Compositions for treating these diseases are also disclosed.Type: ApplicationFiled: December 18, 2024Publication date: April 10, 2025Applicant: Technion Research & Development Foundation LimitedInventors: Asya ROLLS, Dorit FARFARA, Ben KORIN, Hilla AZULAY-DEBBY, Shahar ARMON
-
Publication number: 20250101369Abstract: A method of preparing a composition comprising mycelium along with a cellulose and/or plurality of nanoparticles is described herein. The method comprises inoculating a liquid medium with fungus, the liquid medium comprising nutrients and the cellulose and/or nanoparticles. Further described herein are compositions comprising mycelium along with a cellulose and/or plurality of nanoparticles, as well as articles-of-manufacture comprising such a composition, wherein at least 10% of the cellulose and/or nanoparticles in the composition is incorporated within the mycelium. A method of enhancing fungal growth is also described, comprising contacting the fungus with a liquid medium comprising a polymer which comprises carboxylic acid groups.Type: ApplicationFiled: December 9, 2024Publication date: March 27, 2025Applicant: Technion Research & Development Foundation LimitedInventors: Noam ATTIAS, Jacob GROBMAN, Tiffany ABITBOL
-
Publication number: 20250086788Abstract: A method for quantitative magnetic resonance imaging (MRI), the method includes (a) receiving a sequence of MRI images of an in vivo tissue, by an image registration deep neural network (DNN) module that was trained, by a training process, to impose one or more MRI signal related physical constraints on a content of the sequence of MRI images; and (b) extracting one or more quantitative map from the sequence of MRI images.Type: ApplicationFiled: August 14, 2024Publication date: March 13, 2025Applicants: Technion Research & Development Foundation Limited, MEDICAL RESEARCH & DEVELOPMENT FUND FOR HEALTH SERVICES, BNAI-ZION MEDICAL CENTERInventors: Mordechay Pinchas Freiman, Eyal Hanania, Israe Cohen
-
Publication number: 20250051348Abstract: Mechanophoric compounds featuring one or more, or two or more, clickable group(s), which are capable of being coupled to naturally occurring, synthetic and/or metallic substrates via Click chemistry, method of preparing mechanophoric matrices using the mechanophoric compounds, and mechanophoric matrices obtainable thereby, and uses thereof for detecting force-induced damage in the matrices by a colorimetric change are provided.Type: ApplicationFiled: August 13, 2024Publication date: February 13, 2025Applicant: Technion Research & Development Foundation LimitedInventors: Joshua M. GROLMAN, Yifan LIAO, Hang ZHANG, Charles Eliezer DIESENDRUCK
-
Publication number: 20250027868Abstract: An atomic interferometer system comprises optical tweezers each configured to trap at least one atom therein, an atom source system configured to release atoms, and a controller configured to control the optical tweezers to trap at least one atom released by the atom source system in one of the tweezers, to spatially split a wave function of the trapped atom between at least two of the tweezers, and to at least partially recombine the split atomic wave function in at least one of the tweezers. The atomic interferometer system can also comprise a measuring system configured to measure wavefunction population in each of the tweezers and to display an output pertaining to the wavefunction populations.Type: ApplicationFiled: July 17, 2024Publication date: January 23, 2025Applicant: Technion Research & Development Foundation LimitedInventor: Yoav SAGI
-
Patent number: 12201386Abstract: Systems and methods for performing minimally invasive surgical procedures, especially for removal of tumors, and especially for brain tumors, using a robotically inserted therapeutic probe, which first detects tumorous tissue on a pre-planned path through the patient's tissue, before performing therapeutic procedures on the tissue, such as ablation. This pre-treatment detection procedure is thus able to avoid the destruction of healthy tissue. This also ensures that the therapeutic process indicated in a preoperative surgical plan is only performed on tumorous tissue, without sole reliance on preoperative image indications. This is important for neurosurgical operations performed on the brain, since preoperative images may not be accurate due to brain shift occurring during the procedure. Detection can be performed optically or ultrasonically, and treatment by laser or RF ablation. The probe insertion can be performed at 90° to the insertion axis of the device, thus minimizing passage through healthy tissue.Type: GrantFiled: September 6, 2018Date of Patent: January 21, 2025Assignee: Technion Research & Development Foundation LimitedInventors: Hadas Ziso, David Zarrouk, Moshe Shoham, Menashe Zaaroor
-
Patent number: 12186454Abstract: A scaffold comprising electrospun decellularized ECM of an organ, wherein the decellularized ECM has a similar protein composition to native ECM of the organ. Methods of generating same are also disclosed as well as uses of same.Type: GrantFiled: January 23, 2023Date of Patent: January 7, 2025Assignee: Technion Research & Development Foundation LimitedInventors: Marcelle Machluf, Eyal Zussman, Limor Baruch
-
Patent number: 12189762Abstract: A system, a method and a computer program product for protecting a speculative execution processor from side channel attacks, are disclosed. The system comprises a processing circuitry which performs an execution of a code segment, in one time period and copies, in another time period, only a committed portion of the executed code segment into a memory component which is accessible to read actions by an external processing unit. The speculative instructions are stored in an internal cache memory which is not accessible to read actions by the external processing unit.Type: GrantFiled: June 19, 2020Date of Patent: January 7, 2025Assignee: Technion Research & Development Foundation LimitedInventor: Abraham Mendelson